235 related articles for article (PubMed ID: 1548077)
1. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.
Louise CB; Obrig TG
Infect Immun; 1992 Apr; 60(4):1536-43. PubMed ID: 1548077
[TBL] [Abstract][Full Text] [Related]
2. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
Louise CB; Obrig TG
Infect Immun; 1991 Nov; 59(11):4173-9. PubMed ID: 1937774
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
[TBL] [Abstract][Full Text] [Related]
4. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
Louise CB; Tran MC; Obrig TG
Infect Immun; 1997 Aug; 65(8):3337-44. PubMed ID: 9234795
[TBL] [Abstract][Full Text] [Related]
6. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
Obrig TG; Del Vecchio PJ; Brown JE; Moran TP; Rowland BM; Judge TK; Rothman SW
Infect Immun; 1988 Sep; 56(9):2373-8. PubMed ID: 3044997
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
[TBL] [Abstract][Full Text] [Related]
8. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
9. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
[No Abstract] [Full Text] [Related]
10. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome: clinical picture and bacterial connection.
Parsonnet J; Griffin PM
Curr Clin Top Infect Dis; 1993; 13():172-87. PubMed ID: 8397909
[No Abstract] [Full Text] [Related]
12. Role of bacterial cytotoxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Ashkenazi S
Annu Rev Med; 1993; 44():11-8. PubMed ID: 8476235
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
[TBL] [Abstract][Full Text] [Related]
14. Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome.
Kaye SA; Obrig TG
Thromb Res; 1995 Aug; 79(4):415-21. PubMed ID: 7482445
[No Abstract] [Full Text] [Related]
15. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.
O'Loughlin EV; Robins-Browne RM
Microbes Infect; 2001 May; 3(6):493-507. PubMed ID: 11377211
[TBL] [Abstract][Full Text] [Related]
16. Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.
Hofmann SL
Am J Med Sci; 1993 Dec; 306(6):398-406. PubMed ID: 8266983
[TBL] [Abstract][Full Text] [Related]
17. [A boy suffering from SLT associated hemolytic uremic syndrome].
Sjöblad S; Larsson B; Kahlmeter G; Wadström T
Lakartidningen; 1989 Jul; 86(30-31):2595-6. PubMed ID: 2674572
[No Abstract] [Full Text] [Related]
18. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins.
Tesh VL; O'Brien AD
Mol Microbiol; 1991 Aug; 5(8):1817-22. PubMed ID: 1766367
[TBL] [Abstract][Full Text] [Related]
19. Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with the hemolytic uremic syndrome.
Lopez EL; Diaz M; Devoto S; Grinstein S; Woloj M; Murray BE; Rubeglio E; Mendilaharzu F; Turco M; Vasquez M
Pediatr Infect Dis J; 1991 Jan; 10(1):20-4. PubMed ID: 2003052
[TBL] [Abstract][Full Text] [Related]
20. Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome.
Fernández GC; Rubel C; Dran G; Gómez S; Isturiz MA; Palermo MS
Clin Immunol; 2000 Jun; 95(3):227-34. PubMed ID: 10866130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
